Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6

Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6

Objective We study activation of T helper 17 (Th17) and regulatory T (Treg) cells and induction of apoptosis in cells from patients with systemic lupus erythematosus (SLE) compared with controls and effects of atorvastatin and its simulated interactions with other compounds. Methods Mononuclear cell...

Full description

Bibliographic Details
Main Authors:	Jitong Sun, Pritam Kumar Panda, Shailesh Kumar Samal, Rajeev Ahuja, Sofia Ajeganova, Ingiäld Hafström, Anquan Liu, Johan Frostegård
Format:	Article
Language:	English
Published:	Wiley 2021-09-01
Series:	ACR Open Rheumatology
Online Access:	https://doi.org/10.1002/acr2.11305

Similar Items

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
by: Thomas Gustafsson, et al.
Published: (2020-12-01)

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
by: Sofia Ajeganova, et al.
Published: (2021-07-01)

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
by: Johan Frostegård, et al.
Published: (2021-01-01)

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
by: Shailesh Kumar Samal, et al.
Published: (2022-04-01)

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
by: Ingiäld Hafström, et al.
Published: (2019-02-01)

The expression of interleukin-17 in cutaneous lesions of lupus erythematosus in pediatric-onset systemic lupus erythematosus
by: Govind Suresh Mittal, et al.
Published: (2017-01-01)

Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
by: Björn Svensson, et al.
Published: (2022-12-01)

Dynamical modeling of miR-34a, miR-449a, and miR-16 reveals numerous DDR signaling pathways regulating senescence, autophagy, and apoptosis in HeLa cells
by: Shantanu Gupta, et al.
Published: (2022-03-01)

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
by: Sofia Ajeganova, et al.
Published: (2023-08-01)

Interleukin-6 and disease activity in childhood systemic lupus erythematosus
by: Cahya Dewi Satria, et al.
Published: (2023-11-01)

Correlation between Interleukin-4 and Interleukin-6 and auto antibodies in Systemic Lupus Erythematosus.
by: Sajid N. Abdualkader, et al.
Published: (2010-01-01)

T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
by: Anselm Mak
Published: (2022-03-01)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
by: Hongxu Wang, et al.
Published: (2016-12-01)

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms
by: D. Thiagarajan, et al.
Published: (2020-06-01)

Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis
by: Selvaraja, Malarvili, et al.
Published: (2019)

Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
by: Malarvili Selvaraja, et al.
Published: (2019-01-01)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
by: Zahra Rezaieyazdi, et al.
Published: (2022-01-01)

Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01)

Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
by: Miao Shao, et al.
Published: (2018-01-01)

A Case Series of Cutaneous Lupus Erythematosus Progressing to Systemic Lupus Erythematosus in a Lightning Phase
by: Rajkumar Kannan, et al.
Published: (2023-10-01)

TEN like lupus: A rare initial presentation of lupus erythematosus
by: Richa Kumar, et al.
Published: (2022-01-01)

The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus
by: Bernadete L. Liphaus, et al.
Published: (2010-01-01)

P20 Interleukins as potential factors in assessing the disease activity in systemic lupus erythematosus
by: Elena Rezus, et al.
Published: (2024-03-01)

Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus
by: Karina de Oliveira Peliçari, et al.
Published: (2015-05-01)

The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity
by: W.A. Wan Asyraf, et al.
Published: (2018-12-01)

Correlation of serum interleukin-10 level with disease activity and severity in systemic lupus erythematosus
by: Mervat I Abd Elazeem, et al.
Published: (2018-01-01)

Serum interleukin-18 and interleukin-10 levels in systemic lupus erythematosus: correlation with SLEDAI score and disease activity parameters
by: Sahar Abou El-Fetouh, et al.
Published: (2014-01-01)

Unusual presentation of childhood Systemic Lupus Erythematosus
by: Agarwal Indira, et al.
Published: (2007-11-01)

Coexistence Of Psoriasis And Discoid Lupus Erythematosus
by: Das Nilay Kanti, et al.
Published: (2003-01-01)

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease
by: Shailesh Kumar Samal, et al.
Published: (2023-09-01)

An unusual case of linear cutaneous lupus erythematosus
by: Piyush Kumar, et al.
Published: (2021-01-01)

Chronic cutaneous lupus erythematosus with systemic symptoms or systemic lupus erythematosus?
by: Suresh K. Malhotra, et al.
Published: (2016-01-01)

Widespread pain and pain intensity in patients with early rheumatoid arthritis. A cross‐sectional comparison between smokers and non‐smokers
by: Marie‐Louise Karlsson, et al.
Published: (2019-07-01)

Contribution of increased apoptosis in monocytes and lymphocytes in the etiopathogenesis of systemic lupus erythematosus (SLE)
by: Che Maraina, Che Hussin
Published: (2012)

Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus
by: Katarzyna Pawlak-Buś, et al.
Published: (2021-10-01)

Association between interleukin 12B and interleukin 23R gene polymorphisms and systemic lupus erythematosus: a meta-analysis
by: Jae Hyun Jung, et al.
Published: (2022-01-01)

Influence of vitamin D on cell cycle, apoptosis, and some apoptosis related molecules in systemic lupus erythematosus
by: Nafise Tabasi, et al.
Published: (2015-11-01)

Genetic polymorphisms of interleukin-4 third intron region in the Malaysian patients with systemic lupus erythematosus
by: Chua, K.H., et al.
Published: (2008)

Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus.
by: Chua, K.H., et al.
Published: (2009)

Interleukin-10 gene polymorphism in patients with systemic lupus erythematosus and normal individuals of Kasakh population
by: Z E Omarbekova, et al.
Published: (2003-08-01)